联邦制药 (03933.HK)

+ 收藏

资产负债表(联邦制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
截止日期 2024-06-302023-12-312023-06-302022-12-312022-06-30
报表类型 合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231
上市前/上市后 上市后上市后上市后上市后上市后
原始币种 人民币人民币人民币人民币人民币
流动资产
 现金及现金等价物(元) 6,554,830,000.004,261,989,000.004,744,842,000.004,743,071,000.004,037,956,000.00
 受限制存款及现金(元) 767,077,000.00972,249,000.00674,355,000.00694,704,000.00638,845,000.00
 衍生金融资产流动(元) --1,445,000.001,841,000.00-
 应收账款及票据(元) -6,314,480,000.00---
 预付款项、按金及其他应收款项流动(元) 5,449,617,000.00-5,577,973,000.004,911,704,000.004,083,763,000.00
 存货(元) 2,376,200,000.002,238,483,000.002,191,636,000.002,163,626,000.002,218,773,000.00
 流动资产其他项目(元) --21,834,000.00--
 流动资产合计(元) 15,147,724,000.0013,787,201,000.0013,212,085,000.0012,514,946,000.0010,979,337,000.00
非流动资产
 物业、厂房及设备(元) 6,852,226,000.006,483,406,000.005,983,862,000.005,932,295,000.005,825,419,000.00
 预付款项、按金及其他应收款项非流动(元) 168,363,000.00130,278,000.00130,611,000.0078,476,000.0098,105,000.00
 商誉及无形资产(元) 160,778,000.00136,990,000.0094,603,000.00103,369,000.00114,375,000.00
  其中:商誉(元) 3,031,000.003,031,000.003,031,000.003,031,000.003,031,000.00
    无形资产(元) 157,747,000.00133,959,000.0091,572,000.00100,338,000.00111,344,000.00
 于联营和合营公司投资(元) 7,120,000.007,304,000.007,326,000.007,161,000.00-
 衍生金融资产非流动(元) --995,000.00--
 递延税项资产(元) 87,802,000.0080,800,000.0079,707,000.0080,030,000.0081,342,000.00
 非流动资产其他项目(元) 402,116,000.00391,201,000.00260,771,000.00263,348,000.00255,861,000.00
 非流动资产合计(元) 7,678,405,000.007,229,979,000.006,557,875,000.006,464,679,000.006,375,102,000.00
资产总额(元) 22,826,129,000.0021,017,180,000.0019,769,960,000.0018,979,625,000.0017,354,439,000.00
流动负债
 短期借款(元) 1,009,449,000.00197,853,000.00640,868,000.001,359,358,000.001,654,672,000.00
 融资租赁负债流动(元) 4,551,000.002,509,000.003,317,000.003,744,000.003,830,000.00
 衍生金融负债流动(元) -25,587,000.00478,000.0010,087,000.006,929,000.00
 应付账款及票据(元) 5,349,152,000.006,052,651,000.005,746,664,000.005,317,876,000.004,801,319,000.00
 应付税项(元) 207,747,000.00232,548,000.00207,161,000.00209,478,000.00128,367,000.00
 应付股息及利息(元) 726,811,000.00-363,405,000.00-181,757,000.00
 流动负债其他项目(元) 116,512,000.00115,584,000.00101,840,000.00132,484,000.0089,198,000.00
 流动负债合计(元) 7,414,222,000.006,626,732,000.007,063,733,000.007,033,027,000.006,866,072,000.00
 流动资产净值(元) 7,733,502,000.007,160,469,000.006,148,352,000.005,481,919,000.004,113,265,000.00
 总资产减流动负债(元) 15,411,907,000.0014,390,448,000.0012,706,227,000.0011,946,598,000.0010,488,367,000.00
非流动负债
 长期借款(元) 1,430,000,000.001,299,000,000.00880,000,000.001,095,789,000.00482,198,000.00
 融资租赁负债非流动(元) 12,569,000.004,322,000.004,708,000.003,896,000.005,796,000.00
 衍生金融负债非流动(元) -19,191,000.00239,000.00--
 递延税项负债(元) 368,264,000.00288,080,000.00251,296,000.00194,069,000.00200,877,000.00
 递延收入非流动(元) 27,191,000.0032,237,000.0038,367,000.0043,413,000.0050,303,000.00
 非流动负债合计(元) 1,838,024,000.001,642,830,000.001,174,610,000.001,337,167,000.00739,174,000.00
负债总额(元) 9,252,246,000.008,269,562,000.008,238,343,000.008,370,194,000.007,605,246,000.00
股东权益
 股本(元) 16,965,000.0016,965,000.0016,965,000.0016,965,000.0016,970,000.00
 储备(元) 13,508,488,000.0012,717,813,000.0011,513,563,000.0010,591,121,000.009,732,807,000.00
  其他储备(元) 13,508,488,000.0012,717,813,000.0011,513,563,000.0010,591,121,000.009,732,807,000.00
 归属于母公司股东权益(元) 13,525,453,000.0012,734,778,000.0011,530,528,000.0010,608,086,000.009,749,777,000.00
 非控股权益(元) 48,430,000.00-1,089,000.001,345,000.00-584,000.00
 股东权益其他项目(元) -12,840,000.00---
 股东权益合计(元) 13,573,883,000.0012,747,618,000.0011,531,617,000.0010,609,431,000.009,749,193,000.00
负债及股东权益合计(元) 22,826,129,000.0021,017,180,000.0019,769,960,000.0018,979,625,000.0017,354,439,000.00
公告日期 2024-09-272024-04-292023-09-282023-04-272022-09-23
会计准则 香港会计准则香港会计准则香港会计准则香港会计准则香港会计准则
审计意见 -----
核数师 -----
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院